clinical trial
News
2023.11.27
Oncovita, a spin-off from the Institut Pasteur, has won the call for projects "Innovation in biotherapies and bioproduction" as part of the France 2030...
News
2023.10.02
Malaria is the most deadly vector-borne disease in the world, claiming more than 600,000 lives each year. Vector-borne diseases are caused by an infectious...
News
2023.08.17
Due to population growth and economic development, our planet is experiencing significant changes in natural ecosystems that may lead to the re-emergence of...
News
2023.06.16
In January 2018, Institut Pasteur adopted a new strategic plan for 2019-2023, to boost basic research and increase its impact on human health, with...
News
2023.06.28
Since the 2010s, researchers have been studying the molecular mechanisms underlying deafness of which certain types of so-called sensorineural deafness and...
Document de presse
2023.06.02
The aim of immunotherapy strategies is to use cells in the patient's own immune system to destroy tumor cells. CAR T cell therapy is an immunotherapy that is...
News
2023.06.07
The program is aimed at scientists and physicians who are interested in launching a startup or developing an innovative project within a company, people...
News
2023.06.06
This article is the first in a series devoted to the hopes of HIV-AIDS research, on the occasion of the 40th anniversary of the identification of the virus...
News
2023.09.05
This article is the third in a series devoted to the hopes of HIV-AIDS research, on the occasion of the 40th anniversary of the identification of the virus...
News
2023.09.19
This article is the fourth of a series dedicated to the hopes of HIV/AIDS research, on the occasion of the 40th anniversary of the identification of the...